1st Biotherapeutics

C-408, 338 Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, 16942, South Korea

Overview

Developing breakthrough first-in-class molecular therapeutics.

Total Raised

$22 M

Rounds

Links

Website LinkedIn

Verticals

Pharmaceutical

Therapeutics

Investment History

Series D

Jan 2026$22 M

Investors


No investors are linked to this round yet.

No investors are linked to this round yet.

Funding Timeline

Rounds without known dates remain in the investment history. Unknown amounts are listed separately and excluded from disclosed totals; zero indicates no recorded funding that month.

1st Biotherapeutics has $21,980,000 in disclosed funding across the plotted months. Available history
Month (UTC)	Disclosed funding (USD)	Rounds with undisclosed amounts (count)
Jan 26	21,980,000	0
Feb 26	0	0
Mar 26	0	0
Apr 26	0	0
May 26	0	0
Jun 26	0	0
Jul 26	0	0
Aug 26	0	0
Sep 26	0	0
Oct 26	0	0

Team

Jamie Jae Eun Kim

Chief Executive Officer